Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1002/0471143030.cb2610s51

http://scihub22266oqcxt.onion/10.1002/0471143030.cb2610s51
suck pdf from google scholar
21688255!7162257!21688255
unlimited free pdf from europmc21688255    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid21688255      Curr+Protoc+Cell+Biol 2011 ; Chapter 26 (1): Unit 26.10
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Evaluation of antiseptic antiviral activity of chemical agents #MMPMID21688255
  • Geller C; Finance C; Duval RE
  • Curr Protoc Cell Biol 2011[Jun]; Chapter 26 (1): Unit 26.10 PMID21688255show ga
  • Antiviral antisepsis and disinfection are crucial for preventing the environmental spread of viral infections. Emerging viruses and associated diseases, as well as nosocomial viral infections, have become a real issue in medical fields, and there are very few efficient and specific treatments available to fight most of these infections. Another issue is the potential environmental resistance and spread of viral particles. Therefore, it is essential to properly evaluate the efficacy of antiseptics-disinfectants (ATS-D) on viruses. ATS-D antiviral activity is evaluated by (1) combining viruses and test product for an appropriately defined and precise contact time, (2) neutralizing product activity, and (3) estimating the loss of viral infectivity. A germicide can be considered to have an efficient ATS-D antiviral activity if it induces a >3 or >4 log(10) reduction (American and European regulatory agency requirements, respectively) in viral titers in a defined contact time. This unit describes a global methodology for evaluating chemical ATS-D antiviral activity.
  • |Anti-Infective Agents, Local/*pharmacology[MESH]
  • |Antiviral Agents/*pharmacology[MESH]
  • |Cell Line[MESH]
  • |Cell Survival[MESH]
  • |Coronavirus 229E, Human/drug effects[MESH]
  • |Cross Infection/prevention & control/virology[MESH]
  • |Disinfectants/*pharmacology[MESH]
  • |Drug Evaluation[MESH]
  • |Epithelial Cells/cytology[MESH]
  • |Humans[MESH]
  • |Lung/cytology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box